Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 3
1991 4
1992 10
1993 8
1994 12
1995 8
1996 7
1997 9
1998 11
1999 9
2000 6
2001 17
2002 11
2003 21
2004 15
2005 22
2006 16
2007 9
2008 10
2009 28
2010 14
2011 17
2012 29
2013 22
2014 28
2015 33
2016 20
2017 15
2018 13
2019 10
2020 30
2021 20
2022 9
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

467 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Gautret P, et al. Among authors: brouqui p. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. PMID: 32205204 Free PMC article. Clinical Trial.
COVID-19 re-infection.
Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. Brouqui P, et al. Eur J Clin Invest. 2021 May;51(5):e13537. doi: 10.1111/eci.13537. Epub 2021 Mar 17. Eur J Clin Invest. 2021. PMID: 33675046 Free PMC article. No abstract available.
SARS-CoV-2 reinfection and COVID-19 severity.
Nguyen NN, Houhamdi L, Hoang VT, Delerce J, Delorme L, Colson P, Brouqui P, Fournier PE, Raoult D, Gautret P. Nguyen NN, et al. Among authors: brouqui p. Emerg Microbes Infect. 2022 Dec;11(1):894-901. doi: 10.1080/22221751.2022.2052358. Emerg Microbes Infect. 2022. PMID: 35264078 Free PMC article.
Subcutaneously administered antibiotics: a review.
Jumpertz M, Guilhaumou R, Million M, Parola P, Lagier JC, Brouqui P, Cassir N. Jumpertz M, et al. Among authors: brouqui p. J Antimicrob Chemother. 2022 Dec 23;78(1):1-7. doi: 10.1093/jac/dkac383. J Antimicrob Chemother. 2022. PMID: 36374566 Review.
Natural history of COVID-19 and therapeutic options.
Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Gautret P, et al. Among authors: brouqui p. Expert Rev Clin Immunol. 2020 Dec;16(12):1159-1184. doi: 10.1080/1744666X.2021.1847640. Epub 2020 Dec 24. Expert Rev Clin Immunol. 2020. PMID: 33356661 Review.
Veillonella montpellierensis endocarditis.
Rovery C, Etienne A, Foucault C, Berger P, Brouqui P. Rovery C, et al. Among authors: brouqui p. Emerg Infect Dis. 2005 Jul;11(7):1112-4. doi: 10.3201/eid1107.041361. Emerg Infect Dis. 2005. PMID: 16022792 Free PMC article. Review.
Coxsackie thyroiditis.
Brouqui P, Raoult D, Conte-Devolx B. Brouqui P, et al. Ann Intern Med. 1991 Jun 15;114(12):1063-4. doi: 10.7326/0003-4819-114-12-1063_2. Ann Intern Med. 1991. PMID: 1851403 No abstract available.
Ebola and travel--management of imported cases.
Brouqui P, Ippolito G. Brouqui P, et al. Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt A):561-2. doi: 10.1016/j.tmaid.2014.10.008. Epub 2014 Oct 16. Travel Med Infect Dis. 2014. PMID: 25459430 No abstract available.
467 results